2/20
07:27 am
mdt
Medtronic (NYSE:MDT) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Medtronic (NYSE:MDT) was upgraded by analysts at Mizuho to a "strong-buy" rating.
2/18
09:43 am
mdt
Medtronic (NYSE:MDT) had its price target lowered by analysts at JPMorgan Chase & Co. from $105.00 to $100.00. They now have a "neutral" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target lowered by analysts at JPMorgan Chase & Co. from $105.00 to $100.00. They now have a "neutral" rating on the stock.
2/18
09:43 am
mdt
Medtronic (NYSE:MDT) had its price target lowered by analysts at Leerink Partners from $120.00 to $119.00. They now have an "outperform" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target lowered by analysts at Leerink Partners from $120.00 to $119.00. They now have an "outperform" rating on the stock.
2/18
08:13 am
mdt
Medtronic (NYSE:MDT) had its price target lowered by analysts at Needham & Company LLC from $121.00 to $120.00. They now have a "buy" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target lowered by analysts at Needham & Company LLC from $121.00 to $120.00. They now have a "buy" rating on the stock.
2/18
08:13 am
mdt
Medtronic (NYSE:MDT) had its price target lowered by analysts at Robert W. Baird from $103.00 to $100.00. They now have a "neutral" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target lowered by analysts at Robert W. Baird from $103.00 to $100.00. They now have a "neutral" rating on the stock.
2/18
07:01 am
mdt
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/17
02:24 pm
mdt
Medtronic PLC (MDT) Q3 2026 Earnings Call Highlights: Strong Cardiovascular Growth and ... [Yahoo! Finance]
Low
Report
Medtronic PLC (MDT) Q3 2026 Earnings Call Highlights: Strong Cardiovascular Growth and ... [Yahoo! Finance]
2/17
12:46 pm
mdt
Medtronic plc Q3 2026 Earnings Call Summary [Yahoo! Finance]
Low
Report
Medtronic plc Q3 2026 Earnings Call Summary [Yahoo! Finance]
2/17
07:32 am
mdt
Earnings Snapshot: Medtronic tops FQ3 estimates; reaffirms FY26 organic revenue growth and EPS outlook [Seeking Alpha]
Low
Report
Earnings Snapshot: Medtronic tops FQ3 estimates; reaffirms FY26 organic revenue growth and EPS outlook [Seeking Alpha]
2/17
07:30 am
mdt
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters [Globe and Mail, The (Toronto, Canada)]
Low
Report
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters [Globe and Mail, The (Toronto, Canada)]
2/17
06:45 am
mdt
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters
Medium
Report
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters
2/17
06:44 am
mdt
Medtronic announces first surgery with Hugo™ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic
Medium
Report
Medtronic announces first surgery with Hugo™ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic
2/16
04:20 am
mdt
??????????????? - ??????????????????2026-2035? [CNET News]
Medium
Report
??????????????? - ??????????????????2026-2035? [CNET News]
2/13
10:37 am
mdt
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC. They now have a $116.00 price target on the stock.
Low
Report
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC. They now have a $116.00 price target on the stock.
2/13
08:00 am
mdt
Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery
Low
Report
Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery
2/11
01:56 pm
mdt
Medtronic to announce financial results for its third quarter of fiscal year 2026
Low
Report
Medtronic to announce financial results for its third quarter of fiscal year 2026
2/9
07:00 am
mdt
Medtronic (NYSE:MDT) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $121.00 price target on the stock.
Low
Report
Medtronic (NYSE:MDT) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $121.00 price target on the stock.
2/4
10:15 am
mdt
Medtronic (NYSE:MDT) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Medtronic (NYSE:MDT) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/4
10:13 am
mdt
ZOLL Medical Appoints Eric Knudsen as New CEO [Yahoo! Finance]
Low
Report
ZOLL Medical Appoints Eric Knudsen as New CEO [Yahoo! Finance]
2/3
08:17 am
mdt
Medtronic advances its innovation strategy with intent to acquire CathWorks
Low
Report
Medtronic advances its innovation strategy with intent to acquire CathWorks
2/3
08:02 am
mdt
Medtronic (NYSE:MDT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $117.00 price target on the stock.
Low
Report
Medtronic (NYSE:MDT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $117.00 price target on the stock.
2/2
09:17 am
mdt
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
Low
Report
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
1/31
09:48 pm
mdt
Survey on RDN Procedure Volumes Fuels Optimism for Medtronic (MDT) [Yahoo! Finance]
Low
Report
Survey on RDN Procedure Volumes Fuels Optimism for Medtronic (MDT) [Yahoo! Finance]
1/30
10:58 am
mdt
Medtronic (NYSE:MDT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $114.00 price target on the stock.
Low
Report
Medtronic (NYSE:MDT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $114.00 price target on the stock.
1/29
10:20 pm
mdt
???????????????????? : ???????????(AI)???2035??111?2180???????????????????CAGR20.7%?????? [CNET News]
Low
Report
???????????????????? : ???????????(AI)???2035??111?2180???????????????????CAGR20.7%?????? [CNET News]